feed,title,long_url,short_url
Benzinga,TScan Therapeutics Chief Executive Officer Awarded $3.02M Worth of Stock Options,https://benzinga.com/news/23/06/32894632/tscan-therapeutics-chief-executive-officer-awarded-3-02m-worth-of-stock-options,https://da.gd/snRGIz
Benzinga,Board Member at Everi Hldgs Exercises Options Worth $194K,https://benzinga.com/news/23/06/32894626/board-member-at-everi-hldgs-exercises-options-worth-194k,https://da.gd/V0dKC
Benzinga,"Director at Atreca Acquires Company Stock Options Worth 12,000 Shares",https://benzinga.com/news/23/06/32894621/director-at-atreca-acquires-company-stock-options-worth-12-000-shares,https://da.gd/XcNC
Benzinga,"Chief Financial Officer at TScan Therapeutics Acquires Company Stock Options Worth 632,500 Shares",https://benzinga.com/news/23/06/32894619/chief-financial-officer-at-tscan-therapeutics-acquires-company-stock-options-worth-632-500-shares,https://da.gd/Jw7GMr
Benzinga,TScan Therapeutics Director Awarded $98K Worth of Stock Options,https://benzinga.com/news/23/06/32894616/tscan-therapeutics-director-awarded-98k-worth-of-stock-options,https://da.gd/UHg88
Benzinga,Atreca Director Awarded $14K Worth of Stock Options,https://benzinga.com/news/23/06/32894612/atreca-director-awarded-14k-worth-of-stock-options,https://da.gd/PjcQb9
Benzinga,"Board Member at Atreca Acquires Company Stock Options Worth 12,000 Shares",https://benzinga.com/news/23/06/32894610/board-member-at-atreca-acquires-company-stock-options-worth-12-000-shares,https://da.gd/QVvrA
Benzinga,TScan Therapeutics Board Member Awarded $94K Worth of Stock Options,https://benzinga.com/news/23/06/32894605/tscan-therapeutics-board-member-awarded-94k-worth-of-stock-options,https://da.gd/vp7h8
Benzinga,"Director at TScan Therapeutics Acquires Company Stock Options Worth 35,000 Shares",https://benzinga.com/news/23/06/32894590/director-at-tscan-therapeutics-acquires-company-stock-options-worth-35-000-shares,https://da.gd/RiIOn
Benzinga,"Chief Medical Officer at TScan Therapeutics Acquires Company Stock Options Worth 430,000 Shares",https://benzinga.com/news/23/06/32894581/chief-medical-officer-at-tscan-therapeutics-acquires-company-stock-options-worth-430-000-shares,https://da.gd/AFReG
Benzinga,"Director at ImmunityBio Acquires Company Stock Options Worth 158,263 Shares",https://benzinga.com/news/23/06/32894577/director-at-immunitybio-acquires-company-stock-options-worth-158-263-shares,https://da.gd/3VihF
Benzinga,ImmunityBio Board Member Awarded $436K Worth of Stock Options,https://benzinga.com/news/23/06/32894572/immunitybio-board-member-awarded-436k-worth-of-stock-options,https://da.gd/UtFjyS
Benzinga,Stoke Therapeutics Director Awarded $253K Worth of Stock Options,https://benzinga.com/news/23/06/32894565/stoke-therapeutics-director-awarded-253k-worth-of-stock-options,https://da.gd/b5JaL
Benzinga,"Director at Stoke Therapeutics Acquires Company Stock Options Worth 19,441 Shares",https://benzinga.com/news/23/06/32894560/director-at-stoke-therapeutics-acquires-company-stock-options-worth-19-441-shares,https://da.gd/A6FPs
Benzinga,"Board Member at ImmunityBio Acquires Company Stock Options Worth 158,263 Shares",https://benzinga.com/news/23/06/32894559/board-member-at-immunitybio-acquires-company-stock-options-worth-158-263-shares,https://da.gd/zPatT
